In the Korean population, a previous study identified germline DDX41 variants in 6.1% of patients with AML, MDS, or idiopathic cytopenia of undetermined significance, with disease-specific frequencies of 2.3% in AML and 9.0% in MDS [26]. This evidence concerns the gene DDX41 and acute myeloid leukemia.